RT Journal Article
SR Electronic
T1 Worldwide Effectiveness of Various Non-Pharmaceutical Intervention Control Strategies on the Global COVID-19 Pandemic: A Linearised Control Model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20085316
DO 10.1101/2020.04.30.20085316
A1 Choma, Joshua
A1 Correa, Fabio
A1 Dahbi, Salah-Eddine
A1 Dwolatzky, Barry
A1 Dwolatzky, Leslie
A1 Hayasi, Kentaro
A1 Lieberman, Benjamin
A1 Maslo, Caroline
A1 Mellado, Bruce
A1 Monnakgotla, Kgomotso
A1 Naudé, Jacques
A1 Ruan, Xifeng
A1 Stevenson, Finn
YR 2020
UL http://medrxiv.org/content/early/2020/05/12/2020.04.30.20085316.abstract
AB Background COVID-19 is a virus which has lead to a global pandemic. Worldwide, more than 130 countries have imposed severe restrictions, which form part of a set of non-pharmaceutical interventions (NPI)s. We aimed to quantify the country-specific effects of these NPIs and compare them using the Oxford COVID-19 Government Response Tracker (OxCGRT) stringency index, p, as a measure of NPI stringency.Methods We developed a dual latent/observable Susceptible Infected Recovered Deaths (SIRD) model and applied it on each of 22 countries and 25 states in the US using publicly available data. The observable model parameters were extracted using kernel functions. The regression of the transmission rate, β, as a function of p in each locale was modeled through the intervention leverage, αs, an initial transmission rate, β0 and a typical adjustment time, .Results The world average for the intervention leverage, αs = 0.01 (95% CI 0.0102 - 0.0112) had an ensemble standard deviation of 0.0017 (95% C.I. 0.0014 - 0.0021), strongly indicating a universal behavior.Discussion Our study indicates that removing NPIs too swiftly will result in the resurgence of the spread within one to two months, in alignment with the current WHO recommendations. Moreover, we have quantified and are able to predict the effect of various combinations of NPIs. There is a minimum NPI level, below which leads to resurgence of the outbreak (in the absence of pharmaceutical and clinical advances). For the epidemic to remain sub-critical, the rate with which the intervention leverage αs increases should outpace that of the relaxation of NPIs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSouth African Department of Science and Innovation South African National Research Foundation SA-CERN Program National E-science Postgraduate Teaching and Training Platform IEEEAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data incorporated is publicly available. https://coronavirus.jhu.edu/map.html